Can Borui Biotech stand out in the treatment of lymphoma with the launch of its first biologically innovative drug, Zebedumab?

21st Century Business Herald reporter Zhu Yiyi reports from ShanghaiThe launch of this new drug is not only a major milestone in the development of Brilliant Biology, but also provides new treatment options for domestic lymphoma patients.Multiple indicators with significant clinical efficacyAccording to public information, lymphoma is one of the common hematological malignancies...

Tech >>